Figure 4.
Clinical responses in subjects with infections deemed to be caused by (A) Clostridium difficile BI/NAP1/027 and (B) non-BI/NAP1/027 C difficile strains at baseline (microbiological modified intent to treat population). The estimated adjusted proportions were weighted averages across all strata, constructed using Mehrotra-Railkar continuity-corrected minimum-risk stratum weights. BID, twice daily; EOT, end of treatment; QID, 4 times daily.